
The aim of this review is to zzso the recent developments in the treatment of inflammatory zzso zzso zzso zzso ME represents a major cause of visual loss in zzso and its adequate management is crucial for the maintenance of useful vision in patients with zzso Recent studies favor early treatment of inflammatory ME, even in patients with full visual zzso After zzso the standard treatment zzso for inflammatory ME the authors address novel zzso zzso They review the literature on the efficacy of zzso agents for inflammatory ME and point out their zzso but transient zzso Further, they present recent data on the value of systemic zzso in zzso ME and evaluate the effectiveness of zzso Finally, they propose an zzso for the treatment of inflammatory ME and point out that the individual zzso ratio, especially with systemic zzso therapy, should always be zzso 

